Table 2.
Summary of the studies that reported the TB prevalence among SLE patients.
| Study | Country | Region | SLE-TB | Sample size | PTB | EPTB | Mean age | Period | TB-burden | SLE criteria |
|---|---|---|---|---|---|---|---|---|---|---|
| Feng PH 1982 | Singapore | Asia | 16 | 311 | 13 | 3 | 29 | 1963-1979 | Not high | ACR-1982 |
| Shyam C 1996 | India | Asia | 41 | 309 | 32 | 9 | 28.8 | 1989-1994 | High | ACR-1982 |
| Balakrishnan C 1998 | India | Asia | 17 | 146 | 14 | NR | NR | NR | High | NR |
| Kim HY 1999 | Korea | Asia | 22 | 256 | 22 | 0 | 34 | 1989-1997 | Not high | ACR-1982 |
| Sayarlioglu M 2004 | Turkey | Asia | 20 | 556 | 11 | 9 | 34 | 1978-2001 | Not high | NR |
| Pan JP 2005 | China | Asia | 18 | 426 | 12 | 6 | 30.5 | 1991-2004 | High | ACR-1982 |
| Lei XM 2005 | China | Asia | 42 | 915 | 32 | 18 | 28 | 1995-2004 | High | ACR-1982 |
| Liu G 2006 | China | Asia | 32 | 1678 | 28 | 9 | 34.8 | 2002-2003 | High | ACR-1982 |
| Zhang R 2007 | China | Asia | 93 | 2682 | 73 | 48 | 29.4 | 1997-2006 | High | ACR-1982 |
| Zhang L 2008 | China | Asia | 42 | 452 | 11 | 31 | 34.9 | 1997-2006 | High | ACR-1997 |
| Hou CL 2008 | Taiwan,China | Asia | 21 | 3179 | 10 | 11 | 45 | 1985-2004 | High | ACR-1982 |
| Chu AD 2009 | USA | North America | 6 | 187 | 5 | 4 | 45.2 | 2005 | Not high | ACR-1997 |
| Wang J 2009 | China | Asia | 41 | 1245 | NR | NR | 40.25 | 1990-2001 | High | ACR-1982 |
| González León R 2010 | Spain | Europe | 13 | 789 | 9 | 8 | 36 | 1980-2009 | Not high | NR |
| Pasoto SG 2010 | Brazil | South America | 20 | 1283 | 20 | 0 | 41.9 | 2001-2009 | High | ACR-1997 |
| Ma L 2014 | China | Asia | 8 | 203 | 4 | 4 | 32 | 2007-2011 | High | ACR-1997 |
| Yang Y 2017 | Singapore | Asia | 17 | 841 | 14 | 3 | 53.9 | 2004-2011 | Not high | NR |
| Zhan ZP 2017 | China | Asia | 42 | 782 | 28 | 25 | 31.3 | NR | High | ACR-1997 |
| Torres-González P 2018 | Mexico | North America | 72 | 5365 | 38 | 48 | 35 | 1990-2014 | Not high | ACR-1982 |
| Lao M 2019 | China | Asia | 59 | 1108 | 41 | 18 | 34.4 | 2007-2017 | High | ACR-1997 |
| Song WY2019 | China | Asia | 7 | 141 | 5 | 4 | 35.14 | 2016-2019 | High | NR |
| Hamijoyo L 2019 | Indonesia | Asia | 93 | 813 | NR | NR | 27.7 | 2016-2017 | High | ACR-1997 |
| Ahmmed MF 2019 | Bangladesh | Asia | 23 | 230 | 15 | 8 | NR | 2015-2016 | High | NR |
| González–Naranjo LA 2021 | USA | North America | 67 | 4738 | 54 | 31 | 34 | 2007-2017 | Not high | ACR-1997 |
| Xiao X 2021 | China | Asia | 158 | 10469 | 103 | NR | 37 | 1983-2019 | High | NR |
| Liu X 2021 | China | Asia | 41 | 2959 | NR | 20 | 42 | 2014-2016 | High | NR |
TB, tuberculosis; PTB, pulmonary tuberculosis; NR, not reported; EPTB, extrapulmonary tuberculosis; ACR, American College of Rheumatology.